RLF AgTech (ASX:RLF) signed an exclusive agreement with Axioma Biologicals to register, market, and sell the France-based agricultural biotech firm's liquid biostimulant products across Australia, China, and Asia, according to a Tuesday filing with the Australian bourse.
The agreement is effective until Sept. 30, 2026, with automatic two-year renewals until termination, the filing said.